61 |
Aberrant DNA methylation in human non-small cell lung cancerBrena, Romulo Martin 26 February 2007 (has links)
No description available.
|
62 |
Transcriptional Silencing Of Foxd3 Is An Early Event Mediating Epigenetic Silencing In Tcl1 Positive Chronic Lymphocytic LeukemiaChen, Shih-Shih 09 September 2008 (has links)
No description available.
|
63 |
Dissecting the biology and clinical implications of aberrant DNA methylation in acute myelogenous leukemiaKelly, Andrew David January 2019 (has links)
Acute myeloid leukemia (AML) is a highly lethal malignancy characterized by unchecked expansion of immature myeloid blasts. While certain genetic and cytogenetic aberrations have been associated with chemotherapy response and disease risk, clinical outcomes remain heterogeneous. AML harbors relatively few somatic mutations compared to other cancers, however, it shows marked enrichment for epigenetic regulator alterations, and has been shown to harbor DNA methylation defects. My focus has been to dissect these epigenetic defects using high-throughput DNA methylation data. I first characterized two genome-wide hypermethylation signatures in AML: AML-CpG island methylator phenotype (A-CIMP+), and IDH-associated CIMP (I-CIMP+). While I-CIMP+ leukemias showed significant enrichments for mutations in IDH1 or IDH2, A-CIMP+ cases were mutation independent, and were best defined by their epigenetic defects, and associated transcriptomic changes. Importantly, A-CIMP+ leukemias had relatively favorable clinical outcomes, while I-CIMP+ patients did not. I next sought to characterize epigenetic defects involving demethylation of normally methylated genomic regions. I identified two distinct demethylator phenotypes (DMPs): DMP.1+ and DMP.2+. DMP.1+ AML was largely defined by mutations in DNMT3A, FLT3, and NPM1, while DMP.2+ leukemias harbored favorable-risk genomic rearrangements and a distinct gene expression profile. Both DMPs also carried prognostic information in AML; DMP.1+ cases had poor outcomes, while DMP.2+ patients tended to have favorable survival. Using both CIMP and DMP signatures, I then built an integrated epigenetic model for AML prognosis I termed MethylScore. The MethylScore algorithm was prognostic independent of age and cytogenetic risk in multivariate Cox regression models, suggesting that DNA methylation defects may augment existing clinical tools for risk stratification, and/or treatment selection. Finally, I explored whether DNA methylation signatures and genetic mutations could serve as biomarkers of response to epigenetic therapy, and found that DNA hypermethylation correlated with poor overall survival, and a gene mutation profile was associated with lack of complete remission after treatment with a DNA methylation inhibitor. These data provide evidence of distinct epigenetic signatures in AML that define transcriptionally, genetically, and clinically distinct populations that should be evaluated in future translational/clinical studies. / Biomedical Sciences
|
64 |
Molecular and cellular mechanisms of energy homeostasis in birdsXiao, Yang 09 April 2020 (has links)
Hypothalamus and adipose tissue are essential central and peripheral sites regulating energy homeostasis. Disruption of energy homeostasis can lead to diseases like anorexia and obesity in humans and reduced productivity in animals. Therefore, integrating knowledge in hypothalamic appetite regulation and adipose tissue metabolism is essential to maintain homeostasis. The aim of this dissertation was to elucidate molecular and cellular mechanisms of energy homeostasis in birds. We determined adipose tissue physiological changes during the first two weeks post-hatch in chickens from lines selected for low (LWS) and high (HWS) body weight. LWS was more dependent on yolk and subcutaneous fat mobilization for growth from hatch to day 4 post-hatch, with hyperplasia-predominated replenishment of the reservoir. In contrast, HWS was more dependent on feed for growth and maintained depot mass through hyperplasia and hypertrophy. From day 4 to 14 post-hatch, compared to maintenance of depot weight and adipocyte size in LWS, HWS accumulated clavicular and abdominal fat with minimal lipolysis. There was greater expression of precursor and proliferation markers in LWS with more apoptotic cells in the abdominal stromal vascular fraction on day 14 post-hatch, suggesting that apoptosis contributed to lower adipogenic potential and lack of abdominal fat in LWS. Exposure to thermal and nutritional stressors at hatch impaired growth by reducing yolk utilization and lowering body weight, lean and fat masses in LWS. Stress exposure resulted in increased global DNA methylation and DNA methyltransferase activity in the arcuate nucleus of the hypothalamus in LWS. Moreover, there was decreased binding to methyl-CpG-binding domain protein 2 in the promoter of corticotropin-releasing factor (CRF) because of hypomethylation in one CpG site at its core binding site in stressed LWS, which explains the increased CRF expression in the paraventricular nucleus of the hypothalamus. We next determined effects of nutritional status on adipose tissue physiology in Japanese quail, a less-intensively selected avian species. Six-hour fasting promoted lipolysis and gene expression changes in 7-day old quail with some changes restored to original levels within 1 hour of refeeding. Overall, our results reveal novel cellular and molecular mechanisms regulating appetite and adiposity in birds early post-hatch. / Doctor of Philosophy / Hypothalamus and adipose tissue are essential for regulating energy homeostasis in central and peripheral body sites, respectively. Disruption of energy homeostasis can lead to diseases like anorexia and obesity in humans and reduced productivity in animals. Therefore, integrating knowledge in hypothalamic appetite regulation and adipose tissue metabolism is essential to maintain energy homeostasis in both humans and animals. The aim of this dissertation was to elucidate molecular and cellular mechanisms of energy homeostasis in birds. We first determined adipose tissue physiological changes in chickens during the first two weeks post-hatch from lines selected for low (LWS) and high (HWS) body weight. These chickens have been selected for juvenile body weight for over 60 generations. The LWS are lean and anorexic, while HWS eat compulsively and develop obesity and metabolic syndrome. Such characteristics make the body weight line chickens good animal models to study physiological changes under anorexia and obesity. We found that LWS was more dependent on yolk reserves and subcutaneous fat mobilization for growth from hatch to day 4 post-hatch, with replenishment of the fat reservoir by increases in cell number. By contrast, HWS was more dependent on feed for growth and maintained depot mass through increased cell number and cell size. From day 4 to 14 post-hatch, HWS accumulated fat throughout the body, with less fat breakdown as compared to LWS. There was greater expression of cellular precursor and proliferation markers in LWS, with more dying cells in their abdominal fat on day 14 post-hatch, suggesting that programmed cell death is responsible for the lack of fat cell development in LWS. Exposure to thermal and nutritional stressors at hatch impaired growth by reducing yolk utilization and lowering body weight, lean and fat masses in LWS. There were many molecular changes in the hypothalamus, including changes in DNA that led to increased activation of corticotropin-releasing factor (CRF), a signaling molecule that is known to regulate the body's stress and appetite responses. Stress exposure increased global DNA methylation and DNA methyltransferase activity in the arcuate nucleus of the hypothalamus in LWS. Moreover, there was less methylation at the core binding site of methyl-CpG-binding domain protein 2 (MBD2), a protein that binds to methylated DNA to repress gene expression, in the CRF gene, in stressed LWS. In response to stress, there was decreased binding of MBD2 to the promoter region of CRF, which may explain increased expression of CRF in the paraventricular nucleus of LWS. These results demonstrate that early-life stressful events can cause epigenetic changes (like DNA methylation) that lead to alterations in physiology and behavior that persist to later in life. We next determined effects of nutritional status on adipose tissue physiology in Japanese quail, which have undergone less artificial selection than chickens and are more representative of a wilder-type bird. Six-hour fasting promoted lipolysis and gene expression changes in 7-day old quail with some changes restored to original levels within 1 hour of refeeding. Overall, our results provide novel perspectives on cellular and molecular mechanisms regulating appetite and adiposity in birds during early post-hatch development.
|
65 |
Maintaining Proper Levels of DNA Methylation Marks Through the TET Family is Critical for Normal Embryo Development in PigsUh, Kyung-Jun 24 August 2020 (has links)
DNA methylation is one of the principal epigenetic modifications that plays an essential role in transcriptional regulation. After fertilization, mammalian embryos undergo dynamic changes in genome-wide DNA methylation patterns and the changes are essential for normal embryo development. Ten-eleven translocation (TET) methylcytosine dioxygenases are implicated in DNA demethylation by catalyzing the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC). The three members of TET protein family, TET1, TET2, and TET3, are highly expressed in preimplantation embryos in a stage-specific manner. Previous studies demonstrated that TET proteins are involved in diverse biological processes such as gene regulation, pluripotency maintenance, and cell differentiation by mediating 5mC oxidation. My dissertation research was conducted to elucidate the mechanistic roles of TET proteins in epigenetic reprogramming of mammalian embryos using porcine embryos as a model.
The first set of studies focused on the relationship between TET proteins and pluripotency. To understand the role of TET proteins in establishing pluripotency in preimplantation embryos, CRISPR/Cas9 technology and TET-specific inhibitors were applied. TET1 depletion unexpectedly resulted in an increased expression of NANOG and ESRRB genes in blastocysts, although the DNA methylation levels of NANOG promoter were not changed. Interestingly, transcript abundance of TET3 was increased in blastocysts carrying inactivated TET1, which might have had an effect on the increase of NANOG and ESRRB. When the activity of TET enzymes was inhibited to eliminate the compensatory increase of TET3 under the absence of functional TET1, the expression levels of NANOG and ESRRB were decreased and methylation level of NANOG promoter was increased. In addition, ICM specification was impaired by the inhibition of TET enzymes. These results suggest that the TET family is a critical component of the pluripotency network of porcine embryos by regulating expression of genes involved in pluripotency and early lineage specification. In the next set of studies, the presence of TET3 isoforms in porcine oocytes and cumulus cells was investigated to dissect the gene structure of TET3 that could assist in understanding mechanistic actions of TET3 in the DNA demethylation process. Among the three TET3 isoforms identified in cumulus cells, only the pTET3L isoform, which contains CXXC domain that carry DNA binding property, was verified in mature porcine oocytes. Expression level of the pTET3L isoform was much higher in mature oocytes compared to that in somatic cells and tissues. In addition, the transcript level of this isoform was significantly increased during oocyte maturation. These results suggest that pTET3L isoform is predominantly present in mature porcine oocytes and that CXXC domain may play an important role in DNA demethylation in zygotes. In a follow-up study, the role of the TET3 CXXC domain in controlling post-fertilization demethylation in porcine embryos was investigated by injecting TET3 GFP-CXXC into mature porcine oocytes. The injected CXXC was exclusively localized in the pronuclei, indicating that the CXXC domain may localize TET3 to the nucleus. The CXXC overexpression reduced the 5mC level in zygotes and enhanced the DNA demethylation of the NANOG promoter in 2-cell stage embryos. Furthermore, the transcript abundance of NANOG and ESRRB was increased in blastocysts derived from GFP-CXXC overexpressing zygotes. These results provide an evidence that the CXXC domain of TET3 is critical for post-fertilization demethylation of porcine embryos and proper expression of pluripotency related genes in blastocysts. In the last set of studies, the impact of MBD proteins on porcine embryo development was examined under the hypothesis that competitive binding of MBD and TET proteins to 5mC contributes to the proper maintenance of DNA methylation levels in embryos. Cloning of porcine MBD1, MBD3, and MBD4 from mature oocytes indicates that the genes are highly conserved among different species, implying the involvement of porcine MBD proteins in the maintenance of DNA methylation. MBD1 overexpression in oocytes impaired preimplantation development of porcine embryos, suggesting that the MBD1 overexpression may have negatively affected porcine embryo development because proper DNA methylation levels were not preserved under the high level of MBD1.
Collectively, the studies in my dissertation demonstrate that TET family proteins are important epigenetic players involved in the regulation of pluripotency and reprogramming of DNA methylation, and are thus crucial for normal embryo development. The findings in the dissertation will improve our understanding of epigenetic events occurring in mammalian embryos, and have the potential to overcome epigenetic defects that are observed in pluripotent stem cells and in-vitro derived embryos. / Doctor of Philosophy / Epigenetic modifications are heritable changes affecting the level of gene expression without changing the sequence of the genome. DNA methylation, one of the biggest epigenetic marks in mammalian genome, is often correlated to gene repression. In mammals, DNA methylation patterns are dramatically changed during preimplantation development to acquire embryonic developmental potential. Understanding of the epigenetic changes occurring in preimplantation embryos is necessary for producing healthy domestic animals in agriculture and for developing strategies for the treatment of epigenetic defects in human. Ten-eleven translocation (TET) family enzymes, TET1, TET2, and TET3, are known to function as a DNA methylation modifier by converting 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC). My dissertation research was performed to elucidate the role of TET family during preimplantation development using porcine embryos as a model.
Pluripotency refers to the ability of cells to differentiate into all cell types of a mature organism. Pluripotent cells emerge in embryos as embryonic cells acquire lineage-specific characteristics. The first set of studies focused on the role of TET enzymes in regulating the pluripotency of porcine embryos. The impacts of inhibited activities of TET enzymes on the expression of pluripotency related genes were examined. We found that the inhibition of all TET enzymes leads to a decreased expression of pluripotency related genes, an altered DNA methylation level on a gene segment controlling pluripotency, and the impaired formation of pluripotent cell lineage in porcine embryos. This study demonstrates that the TET family is critical for the acquisition of pluripotency in porcine embryos. In the following sets of studies, the function of TET3 protein in the demethylation process occurring in preimplantation embryos was investigated. Fertilized mammalian embryos undergo genome-wide demethylation process to reset germ cell specific epigenetic marks into the embryonic epigenome. Previous studies indicate that TET3 is responsible for the demethylation process in mammalian embryos, although detailed mechanistic action of TET3 is still elusive. Here, we identified a predominant expression of a specific TET3 gene in porcine oocytes. The TET3 gene contained a CXXC domain, a potential DNA binding module, suggesting that TET3 may mediate DNA demethylation through its DNA binding property. To examine the function of the CXXC domain in TET3-mediated DNA demethylation, isolated CXXC domain was injected into porcine oocytes. The injection of CXXC domain facilitated DNA demethylation in embryos, demonstrating that the DNA binding property of TET3 is important for its functionality. In the last study, we investigated the importance of genes known to interact with TET enzymes in porcine embryos. Methyl-CpG-binding domain proteins (MBDs) have the ability to bind methylated region on the genome and play a critical role in mediating DNA methylation and gene repression. Our hypothesis was that a competitive binding of MBD and TET proteins to methylated regions was critical for proper DNA methylation levels in embryos. We identified that porcine MBD sequences were very similar to other species in terms of gene structure, indicating that the genes could also possess gene repressing activity by competing with TET enzymes during porcine embryo development. Injection of MBD1 mRNA to oocytes impaired normal embryo development, suggesting that the injected MBD1 may have negatively affected early embryo development in pigs by disrupting the proper maintenance of DNA methylation levels.
My dissertation researches demonstrate that maintaining proper DNA methylation levels through the TET family is critical for normal embryo development in pigs. This research assists in improving our understating of epigenetic dynamics occurring in mammalian embryos and offers a potential solution to the epigenetic defects frequently observed in mammalian embryos produced through artificial reproductive technologies and pluripotent stem cells reprogrammed from somatic cells.
|
66 |
Epigenetic and Ubiquitin-Proteasome Mechanisms of Obesity DevelopmentMcFadden, Taylor Marie 14 April 2023 (has links)
Obesity is a major health condition in which little is known about the molecular mechanisms that drive it. The hypothalamus is the primary control center for controlling both food intake and energy expenditure in order to maintain the body's energy balance and dysregulation of molecular processes in this region have been implicated in the development and progression of obesity. Recently, several studies have shown altered DNA methylation of critical appetite genes, including the satiety gene Pomc, in the hypothalamus of rodents fed a high fat obesogenic diet. However, it has not previously been studied whether diet-induced changes in DNA methylation of critical appetite genes in the hypothalamus contributes to the development and persistence of the obesity phenotype. Further, DNA 5-hydroxymethylation (5-hmC) is one type of DNA methylation that is 10 times more abundant in the brain than peripheral tissues. However, to date, no study has been conducted examining whether DNA 5-hmC becomes altered in the brain following weight gain and/or contributes to the obesity phenotype. Additionally, there is also evidence to support that exposure to a high fat diet dysregulates the activity of the ubiquitin-proteasome system, the master regulator of protein degradation in cells, in the hypothalamus of male rodents. Despite this, whether this can occur in both sexes and directly contributes to abnormal weight gain has not been investigated. Here, we used a rodent diet-induced obesity model in combination with quantitative molecular assays and CRISPR-dCas9 manipulations to test the role of hypothalamic 1) DNA 5-hmC levels, 2) Pomc methylation, and 3) dysregulated ubiquitin-proteasome signaling in abnormal weight gain following exposure to obesogenic diets. We found that males, but not females, have decreased levels of DNA 5-hmC in the hypothalamus following exposure to a high fat diet, which tracked body weight. Short-term exposure to a high fat diet, which does not result in significant weight gain, resulted in decreased hypothalamic DNA 5-hmC levels, suggesting these changes occur prior to obesity development. Moreover, decreases in DNA 5-hmC persist even after the high fat diet is removed. Importantly, CRISPR-dCas9 mediated upregulation of DNA 5-hmC enzymes in the male, but not female, hypothalamus significantly reduced the percentage of weight gained on the high fat diet relative to controls. Next, we used the CRISPR-dCas9-TET1 and dCas9-DNMT3a systems to test the role of Pomc DNA methylation in the hypothalamus in abnormal weight gain following acute exposure to a high fat diet in male rats. We found that exposure to a high fat diet increases Pomc DNA methylation and reduces gene expression in the hypothalamus. Despite this, we found that CRISPR-dCas9-TET1-mediated demethylation of Pomc was not sufficient to prevent abnormal weight gain following exposure to a high fat diet. Moreover, CRISPR-dCas9-DNMT3a-mediated methylation of Pomc did not alter weight gain following exposure to standard or high fat diets. Finally, we found that both males and females showed dynamic downregulation of proteasome activity, decreases in proteasome subunit expression and an accumulation of degradation-specific K48 polyubiquitinated proteins in the hypothalamus. However, while the CRISPR-dCas9 system was able to selectively increase some forms of proteasome activity, it was unable to prevent diet-induced proteasome downregulation or abnormal weight gain. Collectively, this data reveals novel, sex-specific differences in the engagement of the ubiquitin proteasome system and role of DNA 5-hydroxymethylation in the hypothalamus during the development of the obesity phenotype. / Doctor of Philosophy / Obesity affects 34% of the American population at an annual cost of more than $340 billion in healthcare and is a risk factor for the development of diabetes and certain cancers. Genetic and environmental factors have also been shown to influence the expression of genes that play a role in the development of obesity. The hypothalamus coordinates many integral activities such as hormone regulation and feed intake and numerous studies have observed altered hypothalamic gene regulation in obesity models. Recently, several studies have shown altered DNA methylation of critical appetite genes, including the satiety gene Pomc, in the hypothalamus of rodents fed a high fat obesogenic diet. However, it has not previously been studied whether diet-induced changes in DNA methylation of critical appetite genes in the hypothalamus contributes to the development and persistence of the obesity phenotype. Further, DNA 5-hydroxymethylation (5-hmC) is one type of DNA methylation that is 10 times more abundant in the brain than peripheral tissues. However, to date, no study has been conducted examining whether DNA 5-hmC becomes altered in the brain following weight gain and/or contributes to the obesity phenotype. Additionally, there is also evidence to support that exposure to a high fat diet dysregulates the activity of the ubiquitin-proteasome system, the master regulator of protein degradation in cells, in the hypothalamus of male rodents. Despite this, whether this can occur in both sexes and directly contributes to abnormal weight gain has not been investigated. In this document, I outline a series of experiments designed to elucidate novel, sex-specific differences in the role of the ubiquitin proteasome system and DNA 5-hydroxymethylation in the hypothalamus during the development of the obesity phenotype.
|
67 |
Hypothalamic mechanisms of appetite regulation involve stress response and epigenetic modificationCao, Chang 03 June 2021 (has links)
Appetite regulation is primarily mediated by the hypothalamus, within which many neurotransmitters that regulate feeding are shared by the stress response circuitry. Stressors, especially those occur during critical periods of life, influence epigenetic programming and gene expression in the long-term. Therefore, the aim of this dissertation was to elucidate how hypothalamic mechanisms of appetite regulation correlate with the stress response and epigenetic modifications, using avian models and intracerebroventricular administration of various appetite-regulating factors. We first administered two methylation modifiers, S-adenosylmethionine (SAM), a methyl donor, and 5-azacytidine (AZA), a methylation inhibitor, to determine their effects on appetite. When measuring food intake immediately post-injection, SAM didn't affect fed or fasted chickens from a line selected for low bodyweight (LWS, individuals with anorexia), but suppressed feeding in fed and fasted broilers. In Japanese quail, SAM transiently induced satiety in fed but not fasted chicks. Intriguingly, AZA increased feeding in fasted LWS but decreased it in fed chicks. While it didn't affect either fed or fasted broilers, AZA induced satiety in both fed and fasted quail. These results suggests that SAM/AZA can directly affect appetite depending on genetics and nutritional state. The LWS chickens, when injected with SAM or AZA on day of hatch, didn't show increased feeding to the orexigenic stimulation of neuropeptide Y central injection on day 5 post-hatch. This suggests that epigenetic modifications occurred following SAM/AZA injection and affect appetite regulation that persisted. In other studies, we injected broilers with prostaglandin E2 (PGE2) or β-melanocyte-stimulating hormone (β-MSH) since their effects on appetite are unknown in meat-type chicks. We found that they both potently induced satiety, but the effective duration was longer in β-MSH-injected birds (up to 9 hours) than in PGE2-injected chicks (lasted for 1.5 hours). They both activated the paraventricular nucleus of the hypothalamus. The satiety induced by β-MSH mainly involved corticotropin-releasing factor and mesotocin, while the effect of PGE2 included ghrelin and brain-derived neurotropic factor. Nevertheless, all affected appetite-related factors have connections with the stress response. Thus, our results demonstrate that the hypothalamic mechanisms underlying anorexia induced by different neuroactive molecules involve the stress response and epigenetic modifications. / Doctor of Philosophy / Eating disorders (EDs) all involve abnormal eating behaviors and altered body weight. These aberrant conditions are associated with a change in metabolism and pose great risk to human health and animal production, and are generally characterized by two opposite outcomes, anorexia and obesity. Although affected by multiple systems within the body, appetite regulation is mainly controlled by the brain, especially the hypothalamus. Thus, it is important to understand the hypothalamic mechanisms underlying the regulation of eating behavior. In the hypothalamus, many neurotransmitters affect multiple pathways, including the stress response and those that regulate appetite. Additionally, stress, especially when occurring during early life, can influence behaviors later in life through inducing epigenetic modifications (changes to the packaging of the DNA nucleotide sequence) that alter gene expression. Therefore, the aim of this dissertation was to elucidate how hypothalamic mechanisms of appetite regulation correlate with the stress response and epigenetic modifications, using avian models. To focus on the effects within the brain, we directly injected various appetite regulating factors into the brain in each of the experiments. Previously, our group demonstrated that early-life cold exposure and delayed food supply changed DNA methylation and affected expression of appetite-related genes and food intake in a chicken line predisposed to anorexia. We herein injected chicks with one of two methylation modifiers, S-adenosylmethionine (SAM), a methyl donor, and 5-azacytidine (AZA), a methylation inhibitor, to evaluate their effects on feeding behavior. When food intake was measured immediately after injection, SAM did not affect food intake in either fed or fasted line chickens from a genetic line selected for low body weight (LWS, individuals with anorexia), but suppressed food intake in both fed and fasted broiler (meat-type chickens) chicks. In Japanese quail, however, SAM only transiently induced satiety in fed chicks but not in fasted ones. Intriguingly, AZA increased food intake in fasted LWS chicks but decreased it in fed chicks, but AZA had no effects on food consumption in either fed or fasted broilers. Additionally, AZA suppressed food intake in both fed and fasted quail. These results suggest that SAM and AZA affect appetite differently depending on genetic background and nutritional states. LWS chickens, when injected with SAM or AZA on day of hatch, did not eat more after being injected with the potent hunger factor, neuropeptide Y, at 5 days of age. This indicates that epigenetic modifications occurred following SAM/AZA injection and had persisting effects on appetite regulation. In the other two studies, we injected broiler chicks with prostaglandin E2 (PGE2), a fatty acid-based molecule, or β-melanocyte-stimulating hormone (β-MSH), a peptide. These two molecules have been reported to regulate feeding behavior in rodents and layer-type chickens, but effects are unknown in broilers. They both potently decreased food intake in broilers, but the effective duration was much longer in β-MSH-injected birds (up to 9 hours) than in PGE2-injected chicks (lasted for 1.5 hours). They both activated the paraventricular nucleus of the hypothalamus, while β-MSH also activated the arcuate nucleus and ventromedial nucleus. We further found that the anorexia induced by β-MSH involved corticotropin-releasing factor, mesotocin, and their receptors, while the effect of PGE2 was associated with a change in ghrelin and brain-derived neurotropic factor gene expression. Nevertheless, all of these affected factors have connections with the stress response. Thus, results indicate that the hypothalamic mechanisms underlying anorexia induced by different neuroactive molecules involve the stress response and epigenetic modifications.
|
68 |
Differential DNA Methylation Analysis of the WNT7A Gene in Embryonic Mouse Hearts Following Maternal Binge Alcohol ConsumptionSayyed, Lara Na Al 01 January 2024 (has links) (PDF)
Excessive drinking during early pregnancy is associated with fetal developmental anomalies [1], particularly affecting heart formation, known as Congenital Heart Disease (CHD). This health concern is underscored by studies that indicate a high incidence of binge drinking among expectant mothers [1]. This research delves into alcohol's role in altering epigenetic patterns across the embryonic cardiac genome, seeking to isolate genes and their specific sites influenced by in utero alcohol exposure.
The theory posits that ethanol-exposed embryonic mouse hearts will exhibit distinctive patterns of methylation in contrast to unexposed controls [2]. To investigate the proposed theory, ethanol was orally delivered to mouse models at a gestational stage critical for heart development, specifically embryonic day 9.5 (E9.5). Subsequently, at embryonic day 11.5 (E11.5)—a pivotal moment in cardiac morphogenesis—the mice were euthanized to harvest the embryonic hearts. The genomic material was then meticulously extracted from these hearts to enable a comprehensive analysis through whole-genome bisulfite sequencing (WGBS).
Preliminary results revealed a marginal shift toward lower methylation levels without broad genomic changes in the ethanol treated samples [7]. Nonetheless, particular genes, like WNT7A gene, have been pinpointed for their suppressed activity following alcohol exposure, guiding further inquiries into aimed methylation changes and epigenetic variations that may illuminate the mechanisms by which maternal alcohol consumption prompts cardiac anomalies in CHD [7]
|
69 |
Efeito de inibidores da metilação de DNA sobre a neurotoxicidade induzida por iodeto de 1-metil-4-fenilpiridínio (MPP+) em modelo de células neuroniais / The effect of DNA methylation inhibitors on 1-methyl-4-phenylpyridinium iodide (MPP +) induced neurotoxicity in cultured neuronal cells modelCantelmo, Rebeca Araujo 09 October 2017 (has links)
A Doença de Parkinson é a segunda doença neurodegenerativa mais comum na atualidade. Cerca de 10% dos casos da doença estão relacionados com fatores genéticos e os outros 90% são devido a fatores ambientais e epigenéticos. Evidências indicam alterações na metilação de genes relacionados ao desenvolvimento da doença de Parkinson. No entanto, não se sabe o efeito de inibidores da metilação de DNA sobre a neurotoxicidade induzida por MPP+, uma neurotoxina que mimetiza processos neurodegenerativos associados ao Parkinson in vitro. Portanto, este trabalho teve como objetivo avaliar o efeito dos inibidores da metilação de DNA (RG108, n-ftaloil-l-triptofano e 5azadC, 5-aza-2´-deoxycytidina) e do doador universal de grupamentos metil (SAM, S-adenosilmetionina) sobre neurotoxicidade induzida por MPP+ em cultura de células imortalizadas (PC12), por meio da análise da viabilidade celular avaliada no teste do MTT (3 - [4,5 dimetiltiazol-2-il] -2,5-difenil-tetrazólio); e da análise de neuritogênese, na presença e na ausência de MPP+. Os resultados demonstraram que: 1. o tratamento com DNMTi (inibidor da DNA metiltransferase) ou com SAM induziram efeito per se sobre a viabilidade celular, apenas quando incubados em altas concentrações e em perídos prolongados (24h); 2. não modificaram a morte celular induzida pelo MPP+, em baixas concentrações, mas agravaram a neurotoxicidade quando incubados em altas concentrações ou por períodos prolongados (24h); 3. essas drogas induziram neuritogênese per se e potencializaram a neuritogênese induzida pelo NGF (fator de crescimento neural); 4. protegeram parcialmente contra a diminuição da neuritogênse induzida pelo MPP+. O conjunto de dados sugere que tanto os DNMTi quanto o SAM podem ser citotóxicos, dependen de suas concentrações e do tempo de exposição à droga. No entanto, essas drogas são capazes de aumentar a neuritogênese (diferenciação celular) e proteger contra a neurotoxicidade celular induzida pelo NGF, em células diferenciadas. / Parkinson\'s disease is the second most common neurodegenerative disease nowadays. About 10% of the disease cases are related to genetic factors and the other 90% are due to environmental and epigenetic factors. Evidence indicates changes in DNA methylation in genes related to the development of Parkinson\'s disease. However, the effect of DNA methylation inhibitors on MPP+-induced neurotoxicity, a drug that mimics neurodegenerative processes associated with Parkinson\'s in vitro, is not known. The aim of this study was to evaluate the effect of DNA methylation inhibitors (RG108, N-phthalyl-L-tryptophan and 5azadC, 5-aza-2?-deoxycytidine) and of the universal donor of methyl group (SAM, S-adenosyl methionine) on: 1. MPP+ -induced neurotoxicity in culture of immortalized cells (PC12), by analysis of cell viability in the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium) test; 2. neuritogenesis, in the presence and absence of MPP +. Results indicated that: 1. treatment with DNMTi or SAM induced effects per se on cell viability only at higher concentrations and after prolonged periods of incubation (24h); 2. DNMTi (DNA methyltransferase inhibitors) and SAM increased cell differentiation and neuritogenesis per se, especially when incubated for 30 minutes, as well as they potentiated NGF-induced neurogenesis; 3. the drugs attenuated MPP+-induced effects on neuritogenesis. Altogether, these data suggests short treatment with both DNMTi and SAM do not cause cellular cytotoxicity (cell death), but are able to increase neuritogenesis (cell differentiation) and protect against MPP+-induced neurotoxicity in differentiated cells.
|
70 |
DACT1 is silenced by CpG methylation in gastric cancer and contributes to the pathogenesis of gastric cancer. / CUHK electronic theses & dissertations collectionJanuary 2011 (has links)
Wang, Shiyan. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2011. / Includes bibliographical references (leaves 123-139). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.
|
Page generated in 0.3192 seconds